Judges Scientific plc
JSCIF
$87.59
$3.093.66%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.42% | 3.41% | 0.88% | 5.28% | 10.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.42% | 3.41% | 0.88% | 5.28% | 10.75% |
| Cost of Revenue | 25.50% | 5.04% | -6.94% | -17.16% | -25.64% |
| Gross Profit | 1.75% | 2.72% | 4.36% | 17.85% | 36.91% |
| SG&A Expenses | 8.96% | 9.14% | 9.33% | 19.92% | 35.79% |
| Depreciation & Amortization | -1.84% | 7.16% | 19.75% | 47.18% | 90.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.64% | 7.39% | 4.78% | 7.39% | 10.86% |
| Operating Income | -13.63% | -17.39% | -19.39% | -5.71% | 10.17% |
| Income Before Tax | -12.36% | -8.00% | -0.67% | 6.27% | 13.67% |
| Income Tax Expenses | -29.26% | -33.62% | -35.63% | -26.64% | -18.17% |
| Earnings from Continuing Operations | -8.20% | -0.51% | 11.62% | 18.28% | 25.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -105.83% | -45.49% | -3.30% | -3.24% | -3.60% |
| Net Income | -10.89% | -1.96% | 11.96% | 18.81% | 26.37% |
| EBIT | -13.63% | -17.39% | -19.39% | -5.71% | 10.17% |
| EBITDA | -5.66% | -12.41% | -16.90% | -7.89% | 2.45% |
| EPS Basic | -11.18% | -2.39% | 11.27% | 16.07% | 21.49% |
| Normalized Basic EPS | -30.26% | -27.94% | -23.68% | -4.26% | 16.03% |
| EPS Diluted | -11.21% | -2.45% | 11.19% | 16.30% | 22.05% |
| Normalized Diluted EPS | -30.28% | -27.97% | -23.74% | -4.40% | 15.78% |
| Average Basic Shares Outstanding | 0.29% | 1.07% | 1.85% | 2.77% | 3.71% |
| Average Diluted Shares Outstanding | 0.30% | 1.09% | 1.90% | 2.85% | 3.83% |
| Dividend Per Share | 13.16% | 12.30% | 13.12% | 15.74% | 19.65% |
| Payout Ratio | 0.32% | 0.20% | 0.05% | 0.06% | 0.09% |